|
Volumn , Issue , 2014, Pages e497-e502
|
Taking on challenging targets: making MYC druggable
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MYC PROTEIN;
ADVERSE EFFECTS;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
GENE EXPRESSION REGULATION;
GENETIC PREDISPOSITION;
GENETIC TRANSCRIPTION;
GENETICS;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
MUTATION;
NEOPLASMS;
PATHOLOGY;
PHENOTYPE;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MOLECULAR TARGETED THERAPY;
MUTATION;
NEOPLASMS;
PHENOTYPE;
PROTO-ONCOGENE PROTEINS C-MYC;
SIGNAL TRANSDUCTION;
TRANSCRIPTION, GENETIC;
TREATMENT OUTCOME;
|
EID: 85003047425
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.e497 Document Type: Review |
Times cited : (50)
|
References (0)
|